These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28935478)

  • 1. Development and validation of a cell based assay for the detection of neutralizing antibodies against recombinant insulins.
    Chatterjee S; Vashishta L; Waichale VS; Nayak VG; Melarkode R; Donnelly CM; Vallano PT; Chirmule N; Sengupta N
    J Immunol Methods; 2018 Jan; 452():53-62. PubMed ID: 28935478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).
    Liao K; Sikkema D; Wang C; Lee TN
    J Immunol Methods; 2013 Mar; 389(1-2):52-60. PubMed ID: 23298658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay.
    Schwickart M; Mehrzai F; Pearson J; Shaghasi N; Chavez C; Schneider A; Wu S; Roskos L; Liang M
    J Immunol Methods; 2014 Jan; 403(1-2):52-61. PubMed ID: 24287421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox.
    Schneider AK; Vainshtein I; Roskos LK; Chavez C; Sun B; Liang M
    J Immunol Methods; 2016 Aug; 435():68-76. PubMed ID: 27220271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
    Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
    J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
    Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
    J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biotin-drug extraction and acid dissociation (BEAD) procedure to eliminate matrix and drug interference in a protein complex anti-drug antibody (ADA) isotype specific assay.
    Niu H; Klem T; Yang J; Qiu Y; Pan L
    J Immunol Methods; 2017 Jul; 446():30-36. PubMed ID: 28389174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
    Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
    J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
    Hermanrud C; Ryner M; Luft T; Jensen PE; Ingenhoven K; Rat D; Deisenhammer F; Sørensen PS; Pallardy M; Sikkema D; Bertotti E; Kramer D; Creeke P; Fogdell-Hahn A;
    J Immunol Methods; 2016 Mar; 430():1-9. PubMed ID: 26779831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
    Wu Y; Li JJ; Kim HJ; Liu X; Liu W; Akhgar A; Bowen MA; Spitz S; Jiang XR; Roskos LK; White WI
    AAPS J; 2015 Nov; 17(6):1417-26. PubMed ID: 26205082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
    Chen XC; Zhou L; Gupta S; Civoli F
    J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel rapid micro-neutralization ELISA for the detection of neutralizing antibodies against Chandipura virus.
    Damle RG; Patil AA; Bhide VS; Pawar SD; Sapkal GN; Bondre VP
    J Virol Methods; 2017 Feb; 240():1-6. PubMed ID: 27856212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
    Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
    J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
    Wei X; Swanson SJ; Gupta S
    J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies.
    Kavita U; Dai Y; Salvador L; Miller W; Adam LP; Levesque PC; Zhang YJ; Ji QC; Pillutla RC
    Hum Gene Ther Methods; 2018 Dec; 29(6):237-250. PubMed ID: 30351228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development.
    Jiang H; Xu W; Titsch CA; Furlong MT; Dodge R; Voronin K; Allentoff A; Zeng J; Aubry AF; DeSilva BS; Arnold ME
    Anal Chem; 2014 Mar; 86(5):2673-80. PubMed ID: 24506335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum.
    Dai Y; Dong H; Gleason C; Mora J; Kolaitis G; Balasubramanian N; Surapaneni S; Kozhich A; Jawa V
    AAPS J; 2023 Apr; 25(3):35. PubMed ID: 37012501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing.
    Xu W; Sank M; Cummings J; Carl S; Juhel M; Gleason C; Dodge R; DeSilva BS; Kolaitis G; Pillutla R
    J Immunol Methods; 2018 Nov; 462():34-41. PubMed ID: 30099014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy.
    Pennucci J; Swanson S; Kaliyaperumal A; Gupta S
    J Biomol Screen; 2010 Jul; 15(6):644-52. PubMed ID: 20508254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay.
    Wu Y; Akhgar A; Li JJ; Yu B; Chen C; Lee N; White WI; Roskos LK
    AAPS J; 2018 Mar; 20(3):49. PubMed ID: 29541868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.